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S  Seminal  studies  K  Key studies  R  Reviews  G  Guidance  MORE  Search for more studies
K  Constricted routes  in to treatment in England (Publ ic Health England, 2013). The qual i ty of specia l is t a lcohol  treatment in England appears  to be improving but
most dependent drinkers  who could benefi t do without i t, perhaps  partly because so few find their way to treatment via  their GPs  and other medical  services .
K  Dual  diagnosis  provis ion in England ([UK] Care Services  Improvement Partnership, 2008). Fi rst national  assessment for England of progress  towards
implementing the good practice set out by government in 2002. Also avai lable are regional  reports .
K  Advancing recovery in US states  (2012). Implementing medication-ass isted therapies  required regulatory, financing and contractual  levers  to overcome staff
res istance.
K  Case management l inks  detoxi fication to treatment (2006). Si ting case managers  at detoxi fication services  transformed them in to gateways  to longer term
treatment, part of a  broader 'recovery revolution' in Phi ladelphia. The l ink is  to the Findings  analys is ; the original  article i s  a lso freely avai lable.
K  Truly integrated dual  diagnosis  care does  work (2006). Rare test of truly integrated substance use and mental  health care for the severely mental ly i l l  found i t
cut subsequent psychiatric and legal  crises .
G  Alcohol  treatment pathways  ([UK] Department of Health, 2009). Officia l  good practice guidance for England on the development of local ly integrated treatment
systems.
G  Organisation and procurement of treatment and brief intervention services  ([UK] National  Insti tute for Health and Cl inical  Excel lence, 2011). From Bri ta in’s
health service standard-setting agency, guidance for commiss ioners  on how to organise and procure services  in an area which implement national  cl inical
guidance and satis fy pol icy requirements .
G  NICE alcohol  use disorders  treatment and care pathways  ([UK] National  Insti tute for Health and Cl inical  Excel lence, 2013). From England's  officia l  health
advisory body, care pathways  and associated resources  and guidance relating to the prevention, diagnosis  and management of a lcohol-related disorders .
G  Alcohol  treatment pathway (Publ ic Health England, 2010). Presentation giving examples  of treatment journey pathways  in England for primary care, structured
community treatment, specia l is t inpatient detoxi fication, and for homeless  patients .
G  Integrated care for drug or a lcohol  users  in Scotland (Report Produced for the Scottish Advisory Committee on Drug Misuse, 2008). Treatment system guidance
including care pathways  and dual  diagnosis .
G  Expert advice on commiss ioning drug and alcohol  treatment ([UK] Joint Commiss ioning Panel  for Mental  Health, 2013). Co-chaired by the Royal  Col lege of
General  Practi tioners  and the Royal  Col lege of Psychiatrists , a  col laboration of leading organisations  and individuals  with an interest in commiss ioning for
mental  health and learning disabi l i ties  offers  practical  advice on how and why to commiss ion effective and efficient treatment services .
G  Alcohol  primary care service framework ([UK] Primary Care Commiss ioning, 2009). Guidance for commiss ioning and resourcing primary care practices  to treat
hazardous, harmful  and dependent drinkers .
G  Systems for treating mental ly i l l  problem drinkers  ([UK] Department of Health, 2002). Key message is  that mainstream mental  health services  should take the
lead on treating ‘dual  diagnosis ’ patients , but should coordinate care with special is t substance misuse services .
MORE  This  search retrieves  a l l  relevant analyses .
For subtopics  go to the subject search page and hot topic on evidence-based commiss ioning.
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What is this cell about? The roles of medical services and interventions within alcohol problem treatment systems implemented across
an administrative area; in particular, their role in creating an effective and cost-effective mix of services which offers patients/clients
attractive access points and appropriate options for moving between services or using them in parallel. Involves commissioning,
contracting and purchasing decisions to meet local needs in the context of resource constraints and national policy. Activities include:
needs assessment; restructuring or re-tendering services; contractual requirements on services to demonstrate evidence-based practice,
meet standards, and implement performance monitoring; and financial or other rewards/sanctions linked to activity, quality or outcomes.
At this distance from the preoccupation with intervention effectiveness, research is scarce, and rarely of the 'gold standard' randomised
controlled trial format. Work focusing on medical services is even rarer, but we can fall back on the studies and reviews which deal with
similar issues across alcohol treatment, to be found in cell E2
Where should I start? Perhaps with this 2013 guidance from a collaboration led by Britain’s general practitioner and psychiatry colleges.
It offers commissioning advice geared to the recovery and outcome-funding era, which takes in (as at 2013) latest NICE guidance.
Commissioning should, said the expert group, be “outcome based” and “recognise recovery as central”. The group also boldly specified
what in their opinion a good drug and alcohol service would look like – of which more below.
Highlighted study Here’s a simple idea from Philadelphia, noted for the recovery-oriented transformation of its treatment system. Locate
clinical case managers at detoxification centres and task them with contacting patients who have been cycling repeatedly through
withdrawal but getting nowhere. Their role then is to motivate the patients to complete detoxification and (for at least a year) to guide
and support them through the follow-on services needed to sustain their recovery. It transformed them from extreme detoxification
repeaters in to patients with typical treatment admission patterns. The effects were felt across the entire caseload of the detoxification
centres in increased capacity (the number of patients treated rose by well over a half), a halving in the proportions of re-detoxification
admissions, and more admissions to longer term care instead of isolated detoxifications – one way to make a reality of this critical link in
the care pathways advocated by NICE.
Issues to think about
 What would a good quality alcohol service look like? This vision of what commissioners should be looking for in an alcohol (and drug)
treatment service is not to be taken lightly, coming as it does from a heavyweight collaboration led by England’s general practitioner and
psychiatry colleges. Take a look at the specifications on page 14 of the document. Note that the list is subheaded, “Key components of a
good quality service”. The experts presumably saw these attributes as the minimum to justify a ‘good quality’ tag. Is this your vision too?
Discuss it with colleagues, size up existing services in your area against it. Here’s some starter questions. Are these the attributes to be
expected of each individual service or (perhaps more realistically) of the local service network? Is this a universally applicable vision, or
one particular to a certain kind of service – the “specialist” teams staffed by “professional health and social care staff”, listed among the
core principles agreed by the expert group? Perhaps they are right in implying that a specialist and professionally staffed service is the
least anyone should expect? Look back at the cell B3 bite (“How do we identify effective clinicians?”) and this advice from reviewers:
“Select and evaluate clinicians based on their ‘track record’ ... assumptions that levels of training, experience, or other simple therapist
variables could account for such differences [in effectiveness] does not hold”. Why not simply recognise what is or is not a good quality
service by how well its patients do, regardless of how it is organised and staffed? Can we specify what consitutes a good quality service
in isolation from the local service and case-mix context; could good quality in one area be poor in another?
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 Are we making progress on systems for treating ‘dual diagnosis’? According to new commissioning advice, one sign of a good quality
substance use service is that it can “manage the full range of complexity of need, including ... mental and associated physical health
needs”. But back in 2002 official UK guidance stressed that when the mental problems are severe, care “should be delivered within
mental health services”, which “have a responsibility to address the needs of people with a dual diagnosis”. In 2011 NICE echoed that
advice. Yet we know that when assessed in 2007, mental health services had not been able to adequately gear up for problem substance
users among their caseloads. At a micro level, some of the reasons why became apparent in interviews with mental health nurses
experienced in working with substance using clients, who to them often seemed to pose an “an impossible challenge” for which they
lacked both skills and support. This is (see cell D2 bite, “Where should I start?”) a classic situation in which training is unable make a
difference, the finding in a study in London which tested a substantial training and supervision investment in dual diagnosis for mental
health case managers. Are things better now – do problem drinkers find welcoming and effective care in mental health services? Should
substance use services take a more prominent role in aiding mental health services, perhaps even skill up to themselves deal with the
psychiatric problems so common among their caseloads? Or would that be counterproductive and possibly dangerous in cases of severe
illness? The issue of how to deal with these crossover patients just does not seem to go away.
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